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Summary
In the female germline, DNA damage has the potential to
induce infertility and even to lead to genetic abnormalities
that may be propagated to the resulting embryo [1, 2]. The
protracted arrest in meiotic prophase makes oocytes partic-
ularly susceptible to the accumulation of environmental
insults, including DNA damage. Despite this significant
potential to harm reproductive capacity, surprisingly little
is known about the DNA damage response in oocytes. We
show that double-strand breaks in meiotically competent
G2/prophase-arrested mouse oocytes do not prevent entry
into M phase, unless levels of damage are severe. This lack
of an efficient DNA damage checkpoint is because oocytes
fail to effectively activate the master regulator of the DNA
damage response pathway, ATM (ataxia telangiectasia
mutated) kinase. In addition, instead of inhibiting cyclin
B-CDK1 through destruction of Cdc25A phosphatase,
oocytes utilize an inhibitory phosphorylation of Cdc25B.
We conclude that oocytes are the only nontransformed cells
that fail to launch a robust G2 phase DNA damage check-
point and that this renders them sensitive to genomic
instability.
Results and Discussion
Mouse Oocytes Enter M Phase in the Presence
of DNA Damage
In somatic cells, at the G2 stage, DNA double-strand breaks
cause the autophosphorylation and subsequent activation of
the master DNA damage checkpoint regulator, ATM (ataxia
telangiectasia mutated) kinase [3, 4]. ATM activation is the
initial step in the establishment of the G2 checkpoint following
DNA damage in the form of DNA double-strand breaks. At the
sites of damage, ATM phosphorylates histone H2AX (gH2AX),
which forms a platform for the recruitment of the necessary
checkpoint and repair factors [5]. The establishment of the
checkpoint requires the ATM-mediated activation of check-
point kinases, Chk1 and Chk2 [6, 7]. Cell-cycle arrest at the
G2 stage is a result of a Chk1/Chk2-dependent degradation
of the Cdc25A phosphatase [8–10], but in some cases the
inhibitory phosphorylation of Cdc25B or Cdc25C [11, 12],
leading to a failure to activate cyclin B-CDK1 [9–11].
The few studies that have been undertaken in fully grown
oocytes hint at the possibility of a limited DNA damage*Correspondence: p.marangos@ucl.ac.uk (P.M.), j.carroll@ucl.ac.uk (J.C.)response [13, 14]. To investigate the DNA damage checkpoint
in oocytes,we initially tested the ability of etoposide, a topoiso-
merase II inhibitor, to cause double-strand breaks as it does
in somatic cells [15]. The data verified that treatment with
etoposide (5 mg/ml for 3 hr) causes DNA damage as evidenced
by the presence of phosphorylated H2AX at Ser139 (gH2AX)
[16] (Figure 1A). Having identified that DNA damage can be
detected at this concentration, we examined the ability of
oocytes to progress intoMphase ofmeiosis I after a 3 hr expo-
sure to increasing concentrations (5–100 mg/ml) of etoposide.
Despite the presence of DNA damage at the lower concentra-
tions tested, oocytes were capable of undergoing germinal
vesicle breakdown (GVBD) and entering M phase at near
normal kinetics (Figure 1B). Etoposide-treated oocytes that
undergo GVBD still show a 6-fold greater gH2AX staining
intensity compared to controls (see Figures S1A and S1B
available online). Thus, the absence of cell-cycle arrest in the
presence of DNA damage is likely to be the result of an inade-
quate DNA damage checkpoint rather than highly efficient
DNA repair mechanisms. As the etoposide concentrations
increased, the rate and the ability to undergo GVBDwere grad-
ually reduced (Figure 1B). In order to achieve an effective
G2/prophase arrest, etoposide concentrations at the upper
end of the dose response (50–100 mg/ml, 3 hr) were necessary;
inducing greater than 80%of oocytes to remain arrested at the
G2/prophase stage after 5 hr of culture (Figure 1B).
The ability to enter M phase in the presence of DNA
damage increases with prolonged culture (Figure 1C). Even
at 100 mg/ml where only approximately 20% of oocytes had
undergone GVBD after 5 hr, this increased to over 60% after
20 hr. This recovery from checkpoint arrest was apparently
not due to DNA repair because gH2AX staining was present
in oocytes that had undergone GVBD (Figures S1C and S1D).
More likely, the increase in GVBDmay be attributed to ‘‘check-
point adaptation,’’ a mechanism seen in somatic cells that
causes the inactivation of the G2 checkpoint despite extensive
and irreversible DNA damage [17].
High Levels of Exposure to Etoposide Activate
an ATM/Chk1-Dependent DNA Damage Checkpoint
Having found that oocytes appear not to launch a powerful
DNA damage checkpoint, we next sought to define the pres-
ence of the major players in the response to DNA damage,
namely ATM and Chk1. In this series of experiments, oocytes
were exposed to etoposide as for the previous experiment
and labeled with antibodies to detect gH2AX and active ATM
as determined by monitoring the autophosphorylation of
ATM at Ser1981 (ATM-P) [3] (Figures 2A–2C). Exposure to
increasing concentrations of etoposide caused an increase
in gH2AX as well as ATM activation (Figures 2A and 2B). By
correlating the fluorescence staining in Figure 2A with the
G2/prophase arrest data from Figure 1B at different etoposide
concentrations, we confirmed a positive relationship between
ATM/gH2AX and G2 arrest (Figure 2C).
The correlation between ATM staining and the occurrence of
G2/prophase arrest suggests that ATM is involved in oocyte
checkpoint activation. To test the specificity of the proposed
role for ATM, we induced DNA damage in the presence of an
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Figure 1. DNA Damage Allows M Phase Entry in Mouse Oocytes
(A) Treatment with 5 mg/ml etoposide for 3 hr causes DNA damage in oocytes. Histone H2AX becomes activated at the sites of damage (gH2AX) and is used
as an immunofluorescence marker for the detection of double-strand breaks. Hoechst is used for DNA staining. G2/prophase-arrested oocytes (GV stage)
are fixed at the end of treatment with or without 5 mg/ml etoposide. n = 3 experiments. Total oocyte number isR20. Scale bars represent 20 mm. The third
lane of panels shows a single oocyte in higher magnification.
(B) The effects of increasing concentrations of etoposide on the rate and timing of GVBD. Etoposide treatment is applied during the GV stage. Following
a 3 hr treatment, oocytes are released from arrest (release from 3-isobutyl-1-methylxanthine [IBMX]) (T = 0 hr), and the timing of GVBD is monitored.
Note that 5 mg/ml of etoposide does not affect the rate and timing of GVBD.
(C) Oocytes that remain arrested 5 hr after exposure to high concentrations of etoposide eventually (20 hr after exposure) enterMphase (GVBD). The data for
the 5 hr group are the same as that in (B). Asterisks on the 5 and 20 hr bars denote a significant difference from nontreated controls (0 mg/ml of etoposide) at
the 5 or 20 hr time point, respectively (*p < 0.0001, unpaired t test). (B) and (C) show data from five experiments. Total oocyte number isR50.
See also Figure S1.
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990ATM kinase inhibitor (ATMi). Under DNA damage conditions
that normally induce the checkpoint in mouse oocytes
(50 mg/ml, 3 hr etoposide), the inhibition of ATM alleviates
the checkpoint and allows M phase entry (Figure 2D). Thus,
when the checkpoint is invoked at high levels of DNA damage,
it is mediated via an ATM-dependent pathway.
The most studied downstream effector of the ATM-depen-
dent G2 checkpoint is Chk1 kinase. We found that etoposide
leads to a dose-dependent activation of Chk1 through the
phosphorylation at Ser317 [7] (Figures S2A–S2C). These data
also reveal that Chk1 remains almost completely inactive at
5 mg/ml of etoposide, which likely underlies the reason why
a DNA damage checkpoint is not activated under these con-
ditions of DNA damage (Figures S2A–S2C). However, at doses
of 100 mg/ml etoposide, there is a major increase in phosphor-
ylated Chk1. The possibility of a direct role of Chk1 in the
activation of the oocyte DNA damage checkpoint was tested
by examining progression through the G2/M transition in the
presence of a dominant-negative form of the kinase (kinase-
dead Chk1-D130A; Chk1D) [7]. These data show that inhibition
of Chk1 kinase during DNA damage leads to oocytes escaping
the G2 checkpoint (Figure S2D). Thus, at the levels of DNA
damage induced by high concentrations of etoposide, weconclude that it is an ATM/Chk1-dependent checkpoint
that is primarily responsible for maintaining the G2/prophase
arrest.
Oocytes Are Refractory to DNA Damage due to a Limited
Ability to Activate ATM
The presence of an ATM/Chk1 pathway shows that oocytes
have a mechanism for sensing DNA damage, yet many
oocytes enter M phase despite the presence of DNA damage
as indicated by gH2AX staining. The reasons for this lack of
fidelity in the induction of the G2 DNA damage checkpoint
may be caused by the detector (ATM) not being very sensitive
or, alternatively, in a failure of the resultant signal to impinge on
the cell-cycle machinery and induce arrest at G2. To test the
sensitivity of the detector, we monitored the levels of gH2AX
and ATM-P in the nuclei of oocytes and blastomeres at
different concentrations of etoposide (Figure 3). To detect
early and immediate signs of DNA damage and to avoid
saturation of the DNA damage response, we reduced the
exposure time to etoposide from 3 hr to 15 min. As in somatic
cells [7, 18], blastomeres showed significant activation of
ATM following DNA damage. ATM activity was high even at
the low levels of etoposide tested (10 mg/ml), and the level of
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Figure 2. An ATM-Dependent DNA Damage Checkpoint Can Be Established at High Levels of Exposure to Etoposide
(A) Increasing concentrations of etoposide lead to a respective increase in the levels of gH2AX and ATM-P (Ser1981). Oocytes were arrested at G2/prophase
at the time of the experiment. Hoechst is used for DNA staining, and primary antibodies against gH2AX and ATM-P have been used for immunofluorescence
and confocal imaging. Representative images from three independent experimentswithR30 oocytes at each concentration are shown. Last two lanes show
single oocytes in higher magnification. Scale bars represent 20 mm.
(B) Relationship between etoposide and activation of H2AX and ATM. The data from (A) are presented as normalized fold change. Fold change in ATM and
H2AX activation was determined by the formula F 2 F0/Fmax 2 F0. F is the mean value of each etoposide treatment, and F0 is the control value where no
etoposide is used (0 mg/ml). Fmax is the highest value of the experiment (exposure to 100 mg/ml etoposide). Error bars indicate SD. Asterisks denote a signif-
icant difference from nontreated controls (0 mg/ml of etoposide) (*p < 0.0001, unpaired t test).
(C) Graph of data extracted from Figures 1B and 2A to illustrate a positive relationship between levels of G2/prophase arrest and active H2AX and ATM.
Fluorescence levels are extracted from (A) and are the same used in (B). Vertical error bars indicate SD of fluorescence levels. The G2/prophase arrest levels
and horizontal SD bars are from the 5 hr time point in Figure 1B.
(D) ATM kinase inhibition (10 mg/ml ATMi) allows entry into M phase (GVBD) in the presence of DNA damage (50 mg/ml etoposide, 3 hr). The level of GVBD is
determined 5 hr after release from IBMX. ATMi is used for the duration of the experiment. Data are from three experiments; total oocyte number isR30. The
asterisk denotes a significant difference from non-ATMi-treated oocytes subjected to etoposide-induced DNA damage (*p < 0.0001, unpaired t test).
See also Figure S2.
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991activation continued to increase through the concentration
range. In contrast, ATM activation in oocytes remained at
basal levels before undergoing an increase at the maximalconcentration of 100 mg/ml (Figures 3A–3C). This activation
profile revealed that for intermediate concentrations of etopo-
side (25 and 50 mg/ml), there was a 15- to 20-fold increase in
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Figure 3. The Insensitivity of the DNA Damage Checkpoint in Oocytes Is Due to Reduced ATM Activity
(A) Oocytes and blastocysts (blastomeres) were treated with 100 mg/ml etoposide for 15 min and examined under similar conditions for activation of ATM
and H2AX. ATMi abolishes detection of active ATM, verifying the specificity of the ATM-P (Ser 1981) antibody. Note that the intensity of staining for both
markers of DNA damage increases with increasing concentration of etoposide. n = 3 experiments. Total oocyte number isR30. Total blastocyst number
isR20. Scale bars represent 20 mm. Last two lanes show single nuclei in higher magnification. White shape denotes the boundaries of the oocyte nucleus.
Scale bars represent 5 mm.
(B) The increase in immunolabeling for active H2AX and ATM at increasing concentrations of etoposide. Plot is of raw fluorescence data obtained by
measuring pixel intensity of nuclear area of oocytes and individual blastomeres at different concentrations of etoposide. Data extracted from (A) correspond
to the 100 mg/ml etoposide treatment in (B).We used the formula F2 F0 (F, F0measured as in Figure 2). This formula was used to remove nonspecific staining
(ATMi shows that basal ATM staining is nonspecific), which allows for a better comparison of the different cell types. All the identifiable blastomeres of
different blastocysts were measured.
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Figure 4. The Oocyte DNA Damage Checkpoint Is Induced by Inhibition of
Cdc25B rather than Degradation of Cdc25A
(A) Increasing concentrations of etoposide cause a respective increase in
the activation of ATM (ATM-P) but do not cause Cdc25A degradation.
(B) Cdc25B Ser323 phosphorylation coincides with high concentrations of
etoposide and therefore establishment of the DNA damage checkpoint.
Ser323 phosphorylation is Chk1 dependent because Chk1 inactivation,
through the use of Chk1D, leads to the inhibition of phosphorylation
(100 mg/ml etoposide). For this experiment, IBMX, which is used to sustain
PKA activity and therefore maintain oocytes in G2/prophase arrest, is re-
placed by roscovitine, a CDK1 inhibitor, in order to keep oocytes arrested
without PKA-dependent Cdc25B phosphorylation. Samples (50 oocytes/
sample) for western blotting were collected immediately after treatment.
Actin was used as loading control. n = 2 experiments.
See also Figure S2.
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993the activation of ATM in cells of the blastocysts compared to
oocytes. This relative difference was 3-fold at a concentration
of 100 mg/ml, as there is an increase in ATM activity in oocytes
at this concentration (Figures 3B and 3C).
A similar comparison of the fold change of gH2AX levels
does not reveal any significant difference in activation
between oocytes and blastomeres (Figures 3B and 3D). It is
possible that in oocytes H2AX becomes phosphorylated
independently of ATM, as has been shown in the liver and
kidneys of ATM knockout mice and in pachytene germ cells
[19, 20]. It is unlikely that the difference in ATM activity is
caused by the asynchronous nature of the cell cycle in indi-
vidual blastomeres, because the levels of total and activated
ATM have been shown to be similar in asynchronous and G2
cells [21]. Therefore, limited ATM activation appears to be
one of the main reasons for the insensitivity of the G2 DNA
damage checkpoint in oocytes. Possible reasons for this
limited ATM activity could be low levels of expression of
ATM, a possibility that is supported by monitoring total ATM
in oocytes as compared to growing oocytes and blastocysts
(Figure S3). The absence in G2/prophase oocytes of extracel-
lular signal-regulated kinase (ERK) 1/2-dependent ATM acti-
vation could also be involved [22]. In addition, ATM activity
is known to be influenced by chromatin structure [3], and
G2/prophase-arrested oocytes are known to have a distinct
chromatin configuration [23] and constitutively active histone
deacetylases [24], either of which may limit the response to
DNA damage (Figure S4).
Inhibition of Cdc25B, and Not Degradation of Cdc25A,
Is Responsible for the Establishment of the Oocyte DNA
Damage Checkpoint
We then investigated downstream of ATM to determine
whether the DNA damage pathway is coupled to the cell-cycle
machinery. In somatic cells, the establishment of the G2
checkpoint requires the phosphorylation of Cdc25A by Chk1
that targets the phosphatase for degradation through the
action of SCF (Skp1-Cullin-F box) ligase [9, 10]. We found
that Cdc25A is stable in oocytes even after the extended
DNA damage protocol (100 mg, 3 hr) that induces high levels
of ATM activation (Figure 4A). Furthermore, in an effort to
directly phosphorylate Cdc25A, we overexpressed Chk1, but
despite this treatment being very effective at inducing G2
arrest (Figure S2E), Cdc25A levels remained unaffected (Fig-
ure S2F). These observations and the fact that a G2 DNA
damage checkpoint can be induced at high levels of DNA
damage (Figures 1B, 2, and 4A) suggest that cell-cycle regula-
tors other than Cdc25A must be involved. A strong candidate
is the vital for female meiosis Cdc25 isoform, Cdc25B [25].
Inhibition of Cdc25B through phosphorylation at Ser323 by
protein kinase A (PKA) is responsible for the physiological
G2/prophase arrest in fully grown oocytes [26, 27]. We tested
the possibility that rather than Cdc25A degradation, check-
point activation requires phosphorylation-dependent inhibi-
tion of Cdc25B. We found that increasing concentrations
of etoposide lead to a respective rise in the inhibitory phos-
phorylation levels of Cdc25B at Ser323. Ser323 phosphoryla-
tion is low following treatment with 5 mg/ml etoposide but(C and D) Data from (B) presented as normalized fold change of ATM-P (C) and
exposed to 100 mg/ml; H2AXg Fmax, GV stage oocytes exposed to 100 mg/ml)
oocyte (GV) value for the same concentration of etoposide (*p < 0.0001, unpai
See also Figures S3 and S4.increases dramatically at high levels of DNA damage
(100 mg/ml etoposide) (Figure 4B). Therefore, the oocyte G2
checkpoint activated by high concentrations of etoposide
appears to be caused by inhibitory phosphorylation of
Cdc25B at Ser323. We then tested whether phosphorylation
of Cdc25B was dependent on Chk1 activation by inducing
DNA damage when Chk1 is inhibited by expression of
Chk1D. Inhibition of Chk1 completely abolishes Cdc25B
phosphorylation (Figure 4B). Thus, although it is formally
possible that phosphorylation of all Cdc25 isoforms may
contribute [6, 11, 12], our data show that an ATM/Chk1-
dependent inhibitory phosphorylation of Cdc25B is involved
in the activation of the G2 checkpoint in oocytes following
extended DNA damage.
We have described how fully grown G2/prophase-arrested
mouse oocytes respond to DNA damage. Surprisingly, we
find that the oocyte, despite its central role in propagation of
the species, is capable of detecting DNA damage but has
a greatly damped ability to establish a G2 checkpoint. Oocytes
can therefore progress from G2/prophase and enter theH2AX (D). Fold change is measured as in Figure 2 (ATM Fmax, blastomeres
. Error bars indicate SD. Asterisks denote a significant difference from the
red t test).
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994meiotic divisions, despite the presence of substantial levels of
DNA damage. It is unclear why oocytes show a marked reduc-
tion in the ability to launch a DNA damage response, including
ATM activation and checkpoint establishment through degra-
dation of Cdc25A. The differences may represent a conflict
between normal meiotic function and the ability to establish
an ATM-mediated G2 DNA damage checkpoint, as well as
a modified importance of Cdc25 isoforms in meiosis and
mitosis [25, 26]. It is possible, however, that the oocyte is
capable of repairing minor DNA damage during the prolonged
G2/prophase arrest and the lengthy meiotic M phases, prior
to embryonic development. Alternatively, it is possible that
DNA damage triggers follicular atresia leading to oocyte
degeneration [28]. Nevertheless, the G2 DNA damage check-
point deficiency in meiosis raises concerns regarding the
mammalian oocyte’s susceptibility to DNA damaging insults.
A major issue is in the potential impact of assisted reproduc-
tive technologies where it may be expected that exposure to
light [29], increased free radical generation [29], and potential
contaminants in culture media [30] could serve to increase
DNA damage. The ability to progress through meiosis while
carrying such damage will almost certainly lead to embryos
with decreased developmental potential.
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